ask="0.2413"
ask_size="4000"
average_daily_volume="2092290"
bid="0.2370"
bid_size="200"
book_value="0.0730"
change="+0.0029"
change_from_200_day_moving_average="0.0422"
change_from_50_day_moving_average="0.0447"
change_from_52_week_high="-0.1521"
change_From_52_week_low="0.1079"
change_in_percent="+1.2340%"
close="0.2379"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-0.0570"
ebitda="-16.83M"
eps_estimate_current_year="-0.0700"
eps_estimate_next_quarter="-0.0300"
eps_estimate_next_year="-0.1000"
ex_dividend_date="N/A"
float_shares="230131000"
high="0.2476"
high_52_weeks="0.3900"
last_trade_date="2/24/2017"
last_trade_price="0.2379"
last_trade_size="1828"
last_trade_time="4:02pm"
low="0.2326"
low_52_weeks="0.1300"
market_capitalization="56.47M"
moving_average_200_day="0.1957"
moving_average_50_day="0.1932"
name="Rexahn Pharmaceuticals
Inc."
notes="N/A"
one_year_target_price="2.5000"
open="0.2398"
pe_ratio="N/A"
peg_ratio="0.0000"
percent_change_from_200_day_moving_average="+21.5934%"
percent_change_from_50_day_moving_average="+23.1143%"
percent_change_from_52_week_high="-39.0000%"
percent_change_from_52_week_low="+83.0000%"
previous_close="0.2350"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="3.2192"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="237368000"
short_ratio="1.8700"
stock_exchange="ASE"
symbol="RNN"
volume="1456508"
weeks_range_52="0.1300 - 0.3900"
